title: Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage.
authors.affiliation: Franz Volhard Clinic, Medical Faculty of the Charité, Humboldt University of Berlin, Berlin, Germany.
authors.forename: D N
authors.initials: DN
authors.lastname: Muller
authors.forename: V
authors.initials: V
authors.lastname: Heissmeyer
authors.forename: R
authors.initials: R
authors.lastname: Dechend
authors.forename: F
authors.initials: F
authors.lastname: Hampich
authors.forename: J K
authors.initials: JK
authors.lastname: Park
authors.forename: A
authors.initials: A
authors.lastname: Fiebeler
authors.forename: E
authors.initials: E
authors.lastname: Shagdarsuren
authors.forename: J
authors.initials: J
authors.lastname: Theuer
authors.forename: M
authors.initials: M
authors.lastname: Elger
authors.forename: B
authors.initials: B
authors.lastname: Pilz
authors.forename: V
authors.initials: V
authors.lastname: Breu
authors.forename: K
authors.initials: K
authors.lastname: Schroer
authors.forename: D
authors.initials: D
authors.lastname: Ganten
authors.forename: R
authors.initials: R
authors.lastname: Dietz
authors.forename: H
authors.initials: H
authors.lastname: Haller
authors.forename: C
authors.initials: C
authors.lastname: Scheidereit
authors.forename: F C
authors.initials: FC
authors.lastname: Luft
mesh_terms: D000804:Angiotensin II; D000808:Angiotensinogen / Q000235:genetics; D000818:Animals; D030801:Animals, Genetically Modified; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D015870:Gene Expression; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D051550:I-kappa B Kinase; D007668:Kidney / Q000098:blood supply / Q000737:chemistry; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008264:Macrophages / Q000473:pathology; D009000:Monocytes / Q000473:pathology; D009205:Myocarditis / Q000473:pathology / Q000517:prevention & control; D009206:Myocardium / Q000737:chemistry; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D009393:Nephritis / Q000473:pathology / Q000517:prevention & control; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D051381:Rats; D012083:Renin / Q000235:genetics; D018808:Transcription Factor AP-1 / Q000037:antagonists & inhibitors; D019010:Vascular Cell Adhesion Molecule-1 / Q000032:analysis
chemical_list: D016328:NF-kappa B; D018808:Transcription Factor AP-1; D019010:Vascular Cell Adhesion Molecule-1; D000808:Angiotensinogen; D000804:Angiotensin II; D017346:Protein Serine-Threonine Kinases; C496559:CHUK protein, human; D051550:I-kappa B Kinase; C496560:IKBKB protein, human; C496565:IKBKE protein, human; D012083:Renin; D001241:Aspirin